Bapineuzumab is an anti-beta-amyloid protein (APP) monoclonal antibody. Bapineuzumab is a humanized IgG1 that recognizes the N terminus of Abeta cleared plaques from the brains. Bapineuzumab can be used for the research of Alzheimers disease (AD)[1][2].
Molecular Weight:
(144.5 kDa)
Purity:
96.62
CAS Number:
[648895-38-9]
Target:
Amyloid-beta
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted